NCT00002342View on ClinicalTrials.gov

A Study of Tecogalan Sodium

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Tecogalan sodium

Trial Locations (1)

10021

Mem Sloan - Kettering Cancer Ctr, New York

Sponsors
All Listed Sponsors
lead

Daiichi Pharmaceuticals

INDUSTRY

NCT00002342 - A Study of Tecogalan Sodium | Biotech Hunter | Biotech Hunter